Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cobamamide
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : Interbat Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
The Role of Cobamamide Supplements in Malnourished Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 13, 2023
Lead Product(s) : Cobamamide
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : Interbat Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable